Related Experiment Video
Updated: Jan 27, 2026

Magnetic and Thermal-sensitive PolyN-isopropylacrylamide-based Microgels for Magnetically Triggered Controlled Release
Published on: July 4, 2017
Magnetic thermosensitive micelles with upper critical solution temperature for NIR triggered drug release
Researchers developed novel magnetic micelles with upper critical solution temperature (UCST) for targeted cancer therapy. These smart micelles release doxorubicin (DOX) effectively when exposed to near-infrared (NIR) light, enhancing treatment outcomes.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- Thermosensitive polymers are crucial for targeted cancer therapy.
- Lower critical solution temperature (LCST) polymers are widely studied, but upper critical solution temperature (UCST) polymers offer unique advantages for drug delivery.
- UCST materials swell and disassemble at higher temperatures, enabling rapid drug release.
Purpose of the Study:
- To develop novel magnetic micelles with UCST for doxorubicin (DOX) delivery.
- To investigate the potential of these micelles for combined photothermal therapy and chemotherapy.
- To evaluate their efficacy in vitro and in vivo.
Main Methods:
- Fabrication of hydrophobic Fe3O4 magnetic nanoparticles (8 nm).
- Envelopment of nanoparticles with amphiphilic poly(AAm-co-AN)-g-PEG (PAAP) to form UCST micelles (Fe3O4@PAAP).
- Evaluation of photothermal effects and drug release kinetics upon near-infrared (NIR) laser irradiation.
- In vitro and in vivo antitumor experiments.
Main Results:
- The Fe3O4@PAAP micelles demonstrated excellent photothermal effects.
- NIR laser irradiation induced burst drug release of DOX from the micelles.
- In vitro and in vivo studies showed significantly enhanced therapeutic effects with DOX-Fe3O4@PAAP micelles and NIR irradiation.
- The platform facilitated in situ drug release and combined photothermal-chemotherapy.
Conclusions:
- Novel UCST magnetic micelles (Fe3O4@PAAP) were successfully developed for targeted doxorubicin delivery.
- The developed system offers a promising platform for combined photothermal-chemotherapy with enhanced therapeutic efficacy.
- This approach holds significant potential for future cancer therapy applications.
More Related Videos
07:47Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
Published on: December 13, 2015
09:56Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Related Concept Videos
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Enthalpy of Solution